The gallbladder is a small, hollow organ situated beneath the liver. It receives bile produced by the liver, concentrates it by absorbing water and electrolytes, and releases it into the intestine, especially after a meal containing fat. Although it contributes to efficient digestion, it is not essential for survival: after its removal, the liver continues to produce bile, which flows directly into the intestine.
The gallbladder forms part of the biliary tract, a system of ducts connecting the liver with the duodenum. Its function depends on coordinated epithelial transport, smooth-muscle contraction, hormonal signals, and neural activity. Its clinical importance arises chiefly from gallstones, which may remain silent or cause obstruction, inflammation, and complications elsewhere in the biliary tract. Less common disorders include abnormal emptying, congenital anomalies, and malignant tumors. Understanding the organ therefore requires attention both to its own structure and to its close anatomical and physiological relationships with the liver, intestine, and pancreas.
Gross anatomy and anatomical relationships
In adults, the gallbladder is usually a pear-shaped sac approximately 7–10 cm long, with a resting capacity commonly described as about 30–50 mL. These measurements vary with fasting, recent food intake, disease, and individual anatomical variation. It occupies a shallow depression on the visceral surface of the liver, between hepatic segments IVb and V. Its upper surface is attached to the liver by connective tissue, while much of its exposed lower surface is covered by peritoneum. The close hepatic attachment explains why severe gallbladder disease can produce adjacent liver changes and why the gallbladder bed is relevant during operative dissection.
Three principal regions are distinguished: the fundus, body, and neck. The rounded fundus may project beyond the liver’s inferior edge near the tip of the right ninth costal cartilage. The body lies against the liver and is related inferiorly to the duodenum and transverse colon. The neck narrows into the cystic duct, sometimes through a funnel-shaped infundibulum. A pouch near the neck, commonly called Hartmann’s pouch, is variable and may become particularly prominent in gallstone disease. A stone lodged in this region can obstruct gallbladder drainage or, in certain circumstances, compress the neighboring hepatic duct.
The cystic duct joins the common hepatic duct to form the common bile duct. The latter generally passes behind the first part of the duodenum and then through or alongside the pancreatic head before opening into the descending duodenum, often together with the pancreatic duct. Distal bile flow is regulated by the sphincter of Oddi, a complex of smooth muscle surrounding the terminal ducts. Spiral mucosal folds within the cystic duct, traditionally called the valves of Heister, are not valves in the usual one-way mechanical sense.
The cystic artery most often arises from the right hepatic artery, but variations in its origin and course are common. Small veins drain into the portal venous system or directly into the liver. Lymph passes through nodes near the gallbladder neck and then toward hepatic and celiac nodal groups. Surgical descriptions often emphasize the hepatocystic triangle, bounded by the cystic duct, common hepatic duct, and inferior liver surface. This differs from Jean-François Calot’s original 1891 triangle, whose superior boundary was the cystic artery. Distinguishing these spaces and recognizing variant ducts and arteries are central to avoiding bile-duct injury.
Microscopic structure and epithelial specialization
The gallbladder wall differs from the standard layered organization of much of the gastrointestinal tract. Its mucosa consists of a simple columnar epithelium overlying a connective-tissue lamina propria. Beneath this lies an irregular smooth-muscle layer, followed by perimuscular connective tissue and either a serosal covering or an adventitial attachment to the liver. The gallbladder lacks both a muscularis mucosae and a true submucosa. This arrangement is important in histology and in interpreting how inflammation or a tumor extends through the wall.
The mucosa forms numerous branching folds, especially when the organ is relatively empty. These folds increase the epithelial surface available for transport. Their appearance can resemble intestinal villi in a section, but the gallbladder does not possess the normal villus-and-crypt organization of the small intestine. Its epithelial cells have apical microvilli, tight junctions, and membrane transport systems suited to absorbing electrolytes and water. Nuclei are generally situated toward the base of the cells. Mucus-secreting glands occur particularly near the neck, whereas most of the body and fundus lack the extensive glandular organization seen in some other digestive organs.
The muscle layer contains interlacing bundles rather than sharply separated circular and longitudinal layers. Contraction reduces gallbladder volume and raises pressure sufficiently to move bile through the cystic duct when downstream resistance permits. Connective tissue around the muscle contains blood vessels, nerves, and lymphatic channels. Because the hepatic surface lacks the same serosal barrier present on the free surface, disease extension toward the liver has a different anatomical pathway from extension toward the peritoneal cavity.
Mucosal outpouchings into or through the muscle are known as Rokitansky–Aschoff sinuses. They become prominent in some forms of chronic gallbladder injury and in adenomyomatosis, a benign condition involving wall thickening, muscular enlargement, and intramural epithelial spaces. They should not be confused with invasive glands in a malignant tumor. Chronic irritation can also produce epithelial metaplasia, including pyloric-type or intestinal-type differentiation. Such changes are interpreted within the entire tissue specimen rather than treated as equivalent to cancer. Examination by histopathology can distinguish ordinary inflammation, metaplasia, dysplasia, invasive malignancy, and unusual inflammatory processes that may appear similar on imaging.
Embryonic development and congenital variation
The gallbladder develops from the embryonic foregut as part of the hepatic diverticulum, an endodermal outgrowth that appears during the fourth week of development. The cranial portion contributes to the liver and its intrahepatic duct system, while a more caudal component gives rise to the gallbladder and cystic duct. The connecting stalk participates in the formation of the extrahepatic bile ducts. Surrounding mesenchyme contributes supporting connective tissue and smooth muscle. Because these structures develop together, congenital gallbladder abnormalities may accompany variations elsewhere in the biliary system.
Developmental variation affects the organ’s shape, number, position, and duct connections. A folded fundus, known as a Phrygian cap because of its resemblance to a historical cap, is generally a harmless shape variant. Septa may partly subdivide the lumen. Gallbladder duplication is rare but clinically important because a second sac may have a separate cystic duct and can be overlooked during imaging or an operation. Complete absence, or agenesis, is also rare. It may be discovered incidentally, and a contracted or unvisualized gallbladder on an initial examination is not by itself proof of agenesis.
Position varies as well. A gallbladder may be partly or substantially embedded within the liver, situated unusually far to the left, or suspended by a relatively long mesentery. An unusually mobile gallbladder can occasionally twist around its vascular and ductal attachments, producing torsion and acute interruption of its blood supply. Left-sided gallbladders may occur with or without reversal of the other abdominal organs. Such variations matter primarily because familiar landmarks may be misleading, particularly where an anomalous cystic duct approaches or joins the major hepatic ducts.
The gallbladder is not universal among vertebrates or even among mammals. Humans, dogs, and many other species possess one, whereas horses and rats lack it. In species without a gallbladder, hepatic bile reaches the intestine without storage in a comparable sac. This diversity illustrates that the organ is an adaptation for regulating bile delivery rather than an indispensable site of bile production. Its presence or absence cannot be explained by a simple distinction between carnivorous and herbivorous diets: species with similar broad feeding categories may differ. Comparative anatomy therefore separates the essential hepatic secretion of bile from the optional storage and concentration functions performed by the gallbladder.
Storage, concentration, and regulated emptying
The liver continuously secretes bile containing bile acids, phospholipids, cholesterol, conjugated bilirubin, electrolytes, and water. Bile acids are synthesized from cholesterol and assist the intestinal handling of dietary lipids. Bilirubin is an excretory product derived mainly from the breakdown of heme. The gallbladder does not manufacture these principal constituents. Instead, during fasting, the pressure relationships within the duct system and resistance at the distal biliary outlet favor diversion of part of the hepatic bile through the cystic duct into the gallbladder.
Gallbladder epithelial cells absorb sodium chloride and other electrolytes, with water following osmotically. This process reduces volume while retaining much of the organic material, so stored bile commonly becomes several times more concentrated than freshly secreted hepatic bile. Concentration is selective rather than a uniform removal of water alone: epithelial transport and secretion also modify acidity and the composition of the luminal fluid. Mucus helps protect the epithelial surface and contributes to the physical environment in which bile constituents remain dispersed. Disturbance of this environment can favor crystal retention.
After food enters the upper small intestine, fats and partially digested proteins stimulate intestinal endocrine cells to release cholecystokinin. This hormone promotes gallbladder contraction and coordinates reduced resistance at the sphincter of Oddi through neural and muscular mechanisms. The vagus nerve also contributes to meal-related activity, including responses beginning before nutrients reach the intestine. Secretin primarily promotes bicarbonate-rich secretion from biliary duct cells rather than serving as the principal stimulus for gallbladder contraction. Emptying is therefore a coordinated response involving the gallbladder, bile ducts, sphincter, and gastrointestinal tract.
Within the intestinal lumen, bile acids and phospholipids support the formation of mixed micelles that carry products of fat digestion toward the absorptive surface. This facilitates absorption of lipids and fat-soluble vitamins. Most bile acids are subsequently reabsorbed, chiefly in the terminal ileum, and returned to the liver through portal blood. This recycling is called the enterohepatic circulation. Only a small proportion of the pool is lost in feces each day and replaced by new hepatic synthesis. The gallbladder participates by concentrating and timing delivery of the circulating pool; it is not the site of most bile-acid synthesis or reabsorption. Fasting does not imply complete inactivity, because partial emptying can occur between meals.
Gallstones and their mechanical consequences
Gallstones form when normally soluble or dispersed bile constituents crystallize, aggregate, and enlarge. Cholesterol stones develop through a combination of cholesterol supersaturation, crystal nucleation, and retention within the gallbladder. Reduced emptying allows crystals to remain long enough to grow, while mucin can provide a matrix for their accumulation. Cholesterol is poorly soluble in water, and its stability in bile depends on its association with bile acids and phospholipids. Thus, stone formation reflects the composition and physical behavior of the whole mixture, not simply the cholesterol concentration in blood.
Pigment stones have a different dominant composition. Black pigment stones are associated with increased bilirubin delivery into bile, including in chronic hemolysis, and also occur in people with cirrhosis. Brown pigment stones more often arise in bile ducts in association with stasis and infection, where microbial enzymes alter conjugated bilirubin and other biliary constituents. Individual stones may contain mixed materials. Stone composition, location, and the underlying disorder are consequently distinct features: not every stone found in the common bile duct originally formed there.
Gallstones are common, but their frequency varies substantially with population, age, sex, ancestry, and the method used to detect them. Estimates in many adult Western populations are around 10–15%, although this range is not universal. Associations include increasing age, obesity, rapid weight loss, pregnancy, and some inherited conditions affecting bile composition or bilirubin metabolism. Many people with gallstones never develop symptoms. The number or size of stones alone does not reliably determine whether symptoms will occur, and an incidental stone does not establish the cause of nonspecific digestive complaints.
Transient obstruction of the cystic duct can produce biliary pain, traditionally called biliary colic. Despite that name, the pain is often steady rather than repeatedly cramping. It typically affects the right upper abdomen or epigastrium, may radiate to the back or right shoulder region, and can last from tens of minutes to several hours. A migrating stone may obstruct the common bile duct, causing impaired bile flow and jaundice. Obstruction near the shared biliary and pancreatic outlet can provoke pancreatitis. An impacted gallbladder-neck or cystic-duct stone can compress the common hepatic duct, producing Mirizzi syndrome. Rarely, a longstanding inflammatory connection to the intestine allows a large stone to enter the bowel and cause gallstone ileus, a form of mechanical intestinal obstruction.
Inflammatory disease and acute complications
Cholecystitis is inflammation of the gallbladder. Acute calculous cholecystitis usually begins with persistent cystic-duct obstruction by a stone. Continued secretion, trapped fluid, and distension increase pressure inside the organ. Venous and lymphatic drainage become impaired, the wall develops edema, and local chemical injury and inflammatory signaling intensify. Bacterial infection may develop, but it is not necessary for the initiating process. This distinguishes acute cholecystitis from the shorter, reversible obstruction responsible for uncomplicated biliary pain.
Typical clinical findings include persistent right upper abdominal pain, localized tenderness, and sometimes fever and an elevated white-cell count. Murphy’s sign describes interruption of inspiration because palpation beneath the right costal margin provokes pain as the descending gallbladder approaches the examiner’s hand. An analogous sonographic sign is tenderness produced when the ultrasound transducer presses directly over the gallbladder. Neither finding is conclusive in isolation. Older adults, critically ill people, and individuals with impaired inflammatory responses may have less typical manifestations.
Severe distension and compromised blood supply can lead to ischemia, gangrene, and perforation. Perforation may produce a localized abscess or, less commonly, widespread biliary peritonitis. Empyema denotes purulent material within the gallbladder. Emphysematous cholecystitis is an uncommon, severe form involving gas in the wall or lumen, often associated with gas-forming organisms and tissue ischemia. Infection can extend beyond the organ and contribute to sepsis. Acute cholangitis, by contrast, is infection of the bile ducts, usually in the presence of obstruction; it is related to but anatomically distinct from cholecystitis.
Acalculous cholecystitis occurs without gallstones. It is particularly associated with major trauma, burns, severe systemic illness, prolonged fasting, and other circumstances that impair gallbladder emptying or blood supply. Its mechanism commonly combines stasis, ischemic injury, and inflammation, and recognition can be difficult because other illnesses dominate the clinical picture. Chronic cholecystitis is characterized by repeated or sustained injury, muscular alteration, and fibrosis, usually in association with stones. The resulting organ may become thick-walled and contracted. Xanthogranulomatous cholecystitis is an unusual destructive inflammatory form with lipid-laden macrophages and extensive fibrosis; it can resemble malignancy radiologically and during an operation, requiring pathological examination for distinction.
Functional disorders and nonmalignant wall lesions
Not every gallbladder-related disorder involves visible stones or acute inflammation. Functional gallbladder disorder describes a clinical syndrome of characteristic biliary pain without gallstones or another structural explanation. In the Rome IV framework, the pain has defined features, including an epigastric or right upper abdominal location, episodes lasting at least 30 minutes, and sufficient severity to interrupt activities or prompt urgent assessment. It is not substantially explained by bowel movements, posture, or acid suppression. These criteria distinguish a specific syndrome from a general attribution of bloating, indigestion, or abdominal discomfort to the gallbladder.
Reduced gallbladder emptying on a standardized radionuclide study can support this diagnosis, but it is not independently diagnostic. The measured ejection fraction depends on fasting duration, medications, the stimulant used, infusion technique, and other physiological conditions. An abnormal value in a person without characteristic symptoms does not establish that the gallbladder is causing illness. The predictive relationship between ejection fraction and response to gallbladder removal is imperfect. Reports of symptoms associated with unusually high ejection fractions have also appeared, but definitions and treatment evidence are less established than for conventional structural disease.
Gallbladder polyps are projections from the wall into the lumen. Many lesions described as polyps on imaging are cholesterol deposits or other non-neoplastic changes rather than true tumors. Cholesterolosis involves lipid accumulation in macrophages within the mucosa and may produce yellow speckling, traditionally termed a strawberry gallbladder. True epithelial polyps include adenomas, while malignant lesions are much less common. Interpretation depends on features such as size, growth, morphology, adjacent wall thickening, and the clinical setting. A small echogenic projection is therefore not synonymous with a precancerous lesion.
Adenomyomatosis produces localized or diffuse wall thickening with prominent Rokitansky–Aschoff sinuses. Tiny intramural spaces and characteristic ultrasound reverberation, often called comet-tail artifacts, can help identify it. It is generally regarded as benign, although distinguishing some appearances from malignancy can be difficult. Calcification of the gallbladder wall, known as porcelain gallbladder, has historically been associated with cancer; later evidence indicates that risk is lower and more variable than early surgical series suggested, and that calcification pattern matters. Gallbladder enlargement may also result from prolonged obstruction, producing a mucus-filled hydrops, whereas wall thickening alone may reflect systemic conditions such as heart failure, hepatitis, or low serum albumin rather than primary gallbladder inflammation.
Gallbladder malignancy
Gallbladder cancer is an uncommon malignancy in many countries, but its frequency shows marked geographic variation. Most cases are adenocarcinomas arising from the epithelium. The disease is often difficult to recognize early because initial symptoms can resemble gallstone disease, and small lesions may cause no distinctive symptoms. Some cancers are discovered incidentally when a gallbladder removed for presumed benign disease undergoes pathological examination. Others present with an infiltrative mass, progressive wall thickening, biliary obstruction, or invasion of adjacent structures.
Established associations include longstanding gallstones and chronic gallbladder inflammation, although the great majority of people with gallstones never develop cancer. Risk also varies with age, certain congenital pancreaticobiliary junction abnormalities, and some chronic infectious exposures, including chronic carriage of Salmonella Typhi in endemic settings. Primary sclerosing cholangitis is another relevant clinical context for evaluating gallbladder lesions. These associations are not interchangeable, and no single one is sufficient to predict an individual outcome. Population differences reflect a combination of environmental, anatomical, infectious, and inherited factors.
A frequently described pathway involves chronic epithelial injury followed by metaplasia, dysplasia, carcinoma in situ, and invasive carcinoma. Not all tumors pass through an observable version of this sequence. Molecular alterations affecting pathways such as TP53 and receptor tyrosine kinase signaling occur in subsets of tumors, and the disease is biologically heterogeneous. The gallbladder’s thin wall and its direct relationship to the liver help explain the potential for local extension. Tumors can also spread through lymphatic channels, along the biliary tract, across the peritoneum, or to distant organs through metastasis.
Assessment distinguishes tumor depth, involvement of the hepatic or peritoneal side, adjacent-organ invasion, regional lymph-node involvement, and distant spread. These features inform cancer staging and the extent of possible resection. Very early tumors confined to the lamina propria may be adequately treated by simple gallbladder removal, whereas deeper localized disease may require additional liver tissue and regional lymph-node removal. Unresectable or metastatic disease is managed using systemic therapies and measures addressing obstruction and symptoms. The evidence base increasingly includes biliary tract cancer trials that group gallbladder tumors with other biliary malignancies, making the anatomical composition of a study important when interpreting its results.
Diagnostic assessment and imaging
Evaluation of suspected gallbladder disease combines symptom pattern, physical examination, laboratory findings, and imaging. No single symptom proves that a gallbladder abnormality is the source of pain. The differential diagnosis includes peptic disease, pancreatic disorders, liver disease, renal conditions, and some thoracic causes of upper abdominal discomfort. Blood tests may identify systemic inflammation, impaired bile flow, or pancreatic injury. Uncomplicated gallbladder stones can coexist with normal laboratory results; marked biochemical cholestasis may instead suggest obstruction beyond the cystic duct.
Ultrasonography is generally the first imaging method used for suspected gallstones or acute gallbladder disease. Stones commonly appear as echogenic structures with posterior acoustic shadowing and may move when body position changes. Ultrasound can assess wall thickness, distension, surrounding fluid, and focal tenderness, as well as the caliber of visible bile ducts. A fasting gallbladder is usually easier to evaluate than a contracted post-meal gallbladder. Wall thickening is nonspecific, and technical limitations include overlying bowel gas, body habitus, and difficulty visualizing parts of the extrahepatic ducts.
Cholescintigraphy, often called a HIDA scan, uses a radiotracer taken up by hepatocytes and excreted into bile. Failure to visualize the gallbladder under appropriate test conditions can support cystic-duct obstruction and acute cholecystitis. Interpretation requires attention to hepatic function, fasting duration, severe intercurrent illness, and the timing of images. With a standardized contraction stimulus, the study can calculate the gallbladder ejection fraction:
where the counts are corrected as appropriate for background and radioactive decay. Reference limits depend on the protocol; a cutoff cannot be transferred uncritically between different methods.
Magnetic resonance imaging, particularly magnetic resonance cholangiopancreatography, depicts fluid-filled ducts noninvasively and is useful for evaluating suspected duct stones, strictures, and anatomical variants. Computed tomography is valuable for complications, alternative diagnoses, and tumor extent, but may miss stones that have attenuation similar to bile. Endoscopic ultrasound can detect small stones and provide detailed images near the distal bile duct. Endoscopic retrograde cholangiopancreatography combines endoscopic access with duct imaging and intervention. Because it carries risks, including pancreatitis, it is used chiefly when an intervention such as duct-stone extraction or drainage is anticipated rather than simply to demonstrate an otherwise uncomplicated gallbladder stone.
Treatment, removal, and physiological adaptation
Treatment depends on the disorder rather than on the mere presence of a gallbladder abnormality. Incidentally detected, asymptomatic stones are commonly managed without an operation, whereas recurrent characteristic symptoms and complications often lead to definitive treatment. Cholecystectomy, the surgical removal of the gallbladder, eliminates the principal reservoir in which gallbladder stones form and prevents recurrence of disease within that organ. It does not remove the liver’s ability to make bile, nor does it guarantee that unrelated abdominal symptoms will disappear. Stones already present in the common bile duct require separate consideration.
Carl Langenbuch performed the first successful cholecystectomy in Berlin in 1882. The operation subsequently evolved from an open abdominal procedure into one commonly performed through laparoscopy. Erich Mühe performed a laparoscopic gallbladder removal in 1985, and Philippe Mouret’s 1987 procedure helped accelerate wider adoption of the technique. Modern laparoscopic surgery uses small incisions, a camera, and long instruments to expose and divide the cystic duct and artery before detaching the gallbladder from the liver. Open surgery remains important in selected circumstances and when safe progress cannot be achieved laparoscopically.
A central operative safety principle is the critical view of safety. Before division, the hepatocystic triangle is cleared of fat and fibrous tissue, the lower gallbladder is separated from the liver bed, and only two structures are seen entering the gallbladder. This is intended to reduce misidentification of a major bile duct as the cystic duct. Severe inflammation or distorted anatomy may lead to alternative approaches, including subtotal cholecystectomy. Intraoperative cholangiography or other imaging methods can clarify duct anatomy and identify some duct stones. Potential complications include bleeding, bile leakage, infection, and injury or later narrowing of the major bile ducts.
For acute inflammatory disease, treatment may include fluid support, analgesia, antibiotics when indicated, and early gallbladder removal when clinically appropriate. In selected patients unable to undergo immediate surgery, image-guided or endoscopic gallbladder drainage can control the local process. Oral bile-acid dissolution has a limited role in carefully selected cholesterol stones and does not offer the same definitive result as removal. After cholecystectomy, bile flows more continuously into the intestine, and most people maintain adequate fat digestion. A minority develop persistent diarrhea, sometimes related to excess bile acids reaching the colon. Persistent or recurrent pain after surgery has multiple possible causes, including retained duct stones, biliary injury, pancreatic disease, or disorders unrelated to the biliary tract; the descriptive term “postcholecystectomy syndrome” does not identify a single mechanism.